Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level-Reference-Cited by-同舟云学术

Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level

Published:2024-06 Issue: Volume:15 Page:157-164
ISSN:2666-3287
Container-title:JAAD International
language:en
Short-container-title:JAAD International

Author:

Meier-Schiesser Barbara,Zecha Christine,Zierold Sarah,Kolm Isabel,Röckel Magdalena,Fröhlich Waltraud,Mittag Nora,Schmitt Christina,Kumbrink Joerg,Hassel Jessica C.,Berking Carola,Nashan Dorothee,French Lars Einar,Vera-González Julio,Dummer Reinhard,Kerl-French Katrin,Heinzerling Lucie

Funder

Swiss Life Stiftung für Chancenreichtum und Zukunft

BMBF Bonn

Publisher

Elsevier BV

Reference36 articles.

1. Checkpoint inhibitors;Heinzerling;Dtsch Ärztebl Int,2019

4. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor;Belum;Eur J Cancer,2016

5. Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients;Nikolaou;Br J Dermatol,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes;International Journal of Molecular Sciences;2024-09-08

2. This Month in JAAD International: July 2024;Journal of the American Academy of Dermatology;2024-07

3. Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors;European Journal of Cancer;2024-05